Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients
Figure 3
ILT3 mRNA is upregulated in PBMC derived from IFN beta treated RRMS patients.
Relative expression of ILT3 mRNA in PBMC derived from IFN beta treated patients with RRMS (n = 10) and sex- and age matched controls (n = 10) as assessed by quantitative PCR (Mann-Whitney U test, **p<0,005). Bars are presented as mean ± S.E.M.